|||
医学Management(处理),指治疗技术、治疗方法(案)、治疗策略等。
供小方参考
方舟子
英国、比利时、捷克、德国的研究人员联合发表马兜铃酸肾病发现20周年的综述,对马兜铃酸肾病的诊断和管理进行了回顾,并指出由于监管不充分,中国和印度仍有数以百万计的人继续暴露在服用马兜铃酸草药带来的重大健康风险中。http://t.itc.cn/UwcwN
The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy: A Narrative Review
It has been 20 years since the first description of a rapidly progressive renal disease that is associated with the consumption of Chinese herbs containing aristolochic acid (AA) and is now termed aristolochic acid nephropathy (AAN). Recent data have shown that AA is also the primary causative agent in Balkan endemic nephropathy and associated urothelial cancer. Aristolochic acid nephropathy is associated with a high long-term risk for renal failure and urothelial cancer, and the potential worldwide population exposure is enormous. This evidence-based review of the diagnostic approach to and management of AAN draws on the authors' experience with the largest and longest-studied combined cohort of patients with this condition. It is hoped that a better understanding of the importance of this underrecognized and severe condition will improve epidemiologic, preventive, and therapeutic strategies to reduce the global burden of this disease.
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-5-19 12:09
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社